Home / Share Price Target / Sanofi
Sanofi India Share Price Target 2024, 2025, 2026 to 2039 With Charts
Sanofi India Limited | |||
 | Symbol: SANOFI | ||
| Price: ₹6,076.7 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers - General | |||
Show Table of Contents
Table of Contents
- 1: Sanofi India Brief Company Overview
- 1.1: Sanofi India Limited: A Leading Pharmaceutical Powerhouse
- 1.2: Sanofi India Financial Performance
- 1.2.1: Is Sanofi India A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Sanofi India Share Price Target For 2024
- 2.1.1: Sanofi India Share Price Target Table For 2024
- 2.1.2: Summary: Sanofi India Share Price Prediction For 2024
- 2.2: Sanofi India Share Price Target For 2025
- 2.2.1: Sanofi India Share Price Target Table For 2025
- 2.2.2: Summary: Sanofi India Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Sanofi India Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Sanofi India Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Sanofi India Past Performance
Sanofi India Brief Company Overview
Sanofi India Limited: A Leading Pharmaceutical Powerhouse
Established in 1956, Sanofi India Limited is a renowned manufacturer and distributor of drugs and pharmaceutical products, operating not only in India and Singapore but also internationally.
Key Products and Services:
- Pharmaceutical products for therapeutic areas such as diabetes, cardiology, epilepsy, and more
- Exports its products globally
Industry Reputation:
Sanofi India Limited has a strong reputation in the pharmaceutical industry, with its products being widely recognized under trusted brands like Lantus, Toujeo, and Combiflam.
Diverse Product Range:
The company boasts a diverse product range, catering to a wide variety of healthcare needs, including antihistamines, vitamins, and supplements.
Commitment:
Sanofi India Limited is committed to providing high-quality healthcare products to patients, as evidenced by its robust distribution network and strong relationships with independent distributors.
Sanofi India Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 20,399.49 Crore | Market valuation of Sanofi India's shares. |
| Revenue (TTM) | 2,851.1 Crore | Total revenue generated by Sanofi India over the past twelve months. |
| Net Income (TTM) | +602.9 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 25.53% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 21.14% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +3.3% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +5.2% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 1.87 | Company's total debt divided by total shareholder equity. |
| Total Debt | 19 Crore | Sum of Sanofi India's current & long-term financial obligations. |
| Total Cash | 406.49 Crore | Total amount of liquid funds available to Sanofi India. |
| Beta | 0.33 | Beta is less than 1 indicating that the Sanofi India's price is less volatile than the market. |
Is Sanofi India A Good Buy For Long Term?
Sanofi India's financial performance indicates a stable revenue stream but a decline in earnings compared to the previous year. Despite prudent debt management, the low profit margin may raise concerns. While the stock has shown positive returns in the past 1 year and 5 years, its current valuation and growth prospects suggest it may not be an optimal long-term investment option.
To predict the Sanofi India's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Sanofi India Share Price Target For 2024
The line chart displays the monthly closing prices of Sanofi India with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Sanofi India shares in 2024, see the table below.
Sanofi India Share Price Target Table For 2024
| Sanofi India's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 6240.00 (+2.68%) | Price Action: Apr 2020 Low |
| 2024 Target 2 | 6170.00 (+1.53%) | Price Action: 13 Nov 2024 Low |
| 2024 Target 1 | 6099.00 (+0.36%) | Price Action: 14 Nov 2024 Low |
| Current Price | 6076.70 | Sanofi India's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 6070.21 (-0.11%) | Price Action: Chart |
| Stop Loss 2 | 6001.80 (-1.24%) | Fibonacci Retracement Extended 40% |
| Stop Loss 3 | 5929.90 (-2.42%) | Price Action: Aug 2018 Low |
Summary: Sanofi India Share Price Prediction For 2024
In summary, Sanofi India has declined by ₹-1990.85, recording a notable -24.68% decrease from 1st January 2024 to 21 Nov 2024. Despite the setback, our analysis of Sanofi India for 2024 predicts an additional rise of 0.36% to 2.68% by the end of 2024 with three potential targets T1: 6099.00, T2: 6170.00, T3: 6240.00. Stop Loss at SL1: 6070.21, SL2: 6001.80, SL3: 5929.90.
Sanofi India has a 52-week high of ₹10524.95, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹5892.79, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Sanofi India.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Sanofi India Share Price Target For 2025
The line chart displays the monthly closing prices of Sanofi India with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Sanofi India shares in 2025, see the table below.
Sanofi India Share Price Target Table For 2025
| Sanofi India's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 8480.65 (+39.56%) | Price Action: Chart |
| 2025 Target 2 | 8322.52 (+36.95%) | Price Action: Chart |
| 2025 Target 1 | 8240.12 (+35.6%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 6076.70 | Sanofi India's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 5550.00 (-8.67%) | Price Action: Apr 2023 Low |
| Stop Loss 2 | 5475.30 (-9.9%) | Price Action: Jan 2023 Low |
| Stop Loss 3 | 5400.00 (-11.14%) | Price Action: May 2023 Low |
Summary: Sanofi India Share Price Prediction For 2025
In summary, Sanofi India has declined by ₹-1990.85, recording a notable -24.68% decrease from 1st January 2024 to 21 Nov 2024. Despite the setback, our analysis of Sanofi India for 2025 predicts an additional rise of 35.6% to 39.56% by the end of 2025 with three potential targets T1: 8240.12, T2: 8322.52, T3: 8480.65. Stop Loss at SL1: 5550.00, SL2: 5475.30, SL3: 5400.00.
Sanofi India has a All-Time high of ₹10524.95, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹5892.79, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Sanofi India, we have created a specific page for that check here: Sanofi India Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Sanofi India Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Sanofi India share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of -2.17% over the next 15 years.
For complete year by year Sanofi India long term share price target from 2024, 2025 to 2039 check the below table.
Sanofi India Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Sanofi India Target | YoY Change % |
|---|---|---|
| 2024 | ₹6,076.7 | [Current Price] |
| 2024 | ₹6,275.82 | 3.27% |
| 2025 | ₹5,541.31 | -11.71% |
| 2026 | ₹4,637.88 | -16.31% |
| 2027 | ₹4,593.84 | -0.95% |
| 2028 | ₹4,843.45 | 5.43% |
| 2029 | ₹4,868.35 | 0.51% |
| 2030 | ₹6,106.31 | 25.42% |
| 2031 | ₹5,881.11 | -3.69% |
| 2032 | ₹5,875.35 | -0.1% |
| 2033 | ₹5,754.28 | -2.07% |
| 2034 | ₹5,238.39 | -8.97% |
| 2035 | ₹5,183.47 | -1.05% |
| 2036 | ₹4,964.6 | -4.23% |
| 2037 | ₹4,930.29 | -0.7% |
| 2038 | ₹4,797.92 | -2.69% |
| 2039 | ₹4,617.64 | -3.76% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Sanofi India Past Performance
- In 2002, Sanofi India opening price was ₹370
- As of Thu 21 Nov 2024 the price stands at ₹6,076.7.
- This represents a Compound Annual Growth Rate (CAGR) of 12.94%.
- In 22 years, an investment of 10,000 would have become ₹1.64 Lakh.
As we wrap up, we hope you like our study on Sanofi India share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
